EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease

被引:22
作者
Vorobyov, VV
Schibaev, NV
Morelli, M
Carta, AR
机构
[1] Univ Cagliari, Dept Toxicol, I-09124 Cagliari, Italy
[2] Russian Acad Sci, Inst Cell Biophys, Pushchino 142290, Moscow Region, Russia
[3] Russian Acad Sci, Dept Bioorgan Chem Inst, Pushchino 142290, Moscow Region, Russia
关键词
priming; EEG; cortex; striatum;
D O I
10.1016/S0006-8993(03)02528-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In rats bearing a unilateral 6-hydroxydopamine (6-OHDA) lesion of the medial forebrain bundle, a single administration of a dopamine receptor agonist (priming) sensitizes the behavioral motor responses to a dopaminergic agonist, administered 3 days after priming. In this study, changes in the electroencephalogram (EEG) frequency spectra were evaluated during priming in unilaterally 6-OHDA-lesioned rats, implanted bilaterally with electrodes both in the somatosensory cortex and striatum. Two weeks after 6-OHDA lesion, rats were primed with apomorphine (0.2 mg/kg) and received a challenge with the D, agonist SKF 38393 (3 mg/kg) 3 days later. 6-OHDA lesion modified the EEG pattern mainly in the beta(1) frequency band, in both cortex and striatum. Apomorphine priming produced a power decrease in the beta(1) frequency band, more pronounced in the cortex than in the striatum, as compared to saline-treated rats. Antagonism of NMDA receptor with MK-801, a treatment known to block the development of priming, increased apomorphine inhibitory effect mainly in the striatum, producing the same degree of inhibition in the two structures. Administration of SKF 38393, 3 days after priming, caused a power decrease in P, frequency band of the cortex and striatum, which was more pronounced in apomorphine-primed as compared to drug-naive rats. The inhibitory effect of SKF 38393 was enhanced in rats primed with MK-801 plus apomorphine, particularly in the striatum. The results of this study suggest that long-term changes in the electrical activity of cortex and striatum after priming, might contribute to the development of the behavioral sensitization observed after priming. Development of priming might be related to the degree and cortical/ striatal ratio of EEG power inhibition produced by dopamine agonists. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:177 / 185
页数:9
相关论文
共 53 条
[41]   METABOLIC MAPPING OF THE SYNERGISM BETWEEN MK-801 AND SKF-38393 IN RATS WITH UNILATERAL LESIONS OF THE DOPAMINERGIC NIGROSTRIATAL PATHWAY [J].
PONTIERI, FE ;
MORELLI, M ;
ORZI, F ;
TERENZI, R ;
DICHIARA, G .
SYNAPSE, 1992, 12 (04) :255-260
[42]   Effects of medial thalamotomy and pallido-thalamic tractotomy on sleep and waking EEG in pain and parkinsonian patients [J].
Roth, C ;
Jeanmonod, D ;
Magnin, M ;
Morel, A ;
Achermann, P .
CLINICAL NEUROPHYSIOLOGY, 2000, 111 (07) :1266-1275
[43]   Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission [J].
Sebban, C ;
Zhang, XQ ;
Tesolin-Decros, B ;
Millan, MJ ;
Spedding, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (05) :1045-1054
[44]   GAMMA-AMINOBUTYRIC-ACID RELEASE IN THE GLOBUS-PALLIDUS INVIVO AFTER A 6-HYDROXYDOPAMINE LESION IN THE SUBSTANTIA-NIGRA OF THE RAT [J].
SEGOVIA, J ;
TOSSMAN, U ;
HERRERAMARSCHITZ, M ;
GARCIAMUNOZ, M ;
UNGERSTEDT, U .
NEUROSCIENCE LETTERS, 1986, 70 (03) :364-368
[45]   EFFECTS OF APOMORPHINE IN QUANTIFIED ELECTROENCEPHALOGRAPHY IN THE FRONTAL-CORTEX - CHANGES WITH DOSE AND TIME [J].
SHVALOFF, A ;
TESOLIN, B ;
SEBBAN, C .
NEUROPHARMACOLOGY, 1988, 27 (12) :1313-1317
[46]   MESSENGER-RNAS ENCODING GLUTAMATE-DECARBOXYLASES ARE DIFFERENTIALLY AFFECTED BY NIGROSTRIATAL LESIONS IN SUBPOPULATIONS OF STRIATAL NEURONS [J].
SOGHOMONIAN, JJ ;
GONZALES, C ;
CHESSELET, MF .
BRAIN RESEARCH, 1992, 576 (01) :68-79
[47]   SLOWING OF EEG IN PARKINSONS-DISEASE [J].
SOIKKELI, R ;
PARTANEN, J ;
SOININEN, H ;
PAAKKONEN, A ;
RIEKKINEN, P .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1991, 79 (03) :159-165
[48]   Quantitative EEG changes in non-demented Parkinson's disease patients before and during L-dopa therapy [J].
Stanzione, P ;
Marciani, MG ;
Maschio, M ;
Bassetti, MA ;
Spanedda, F ;
Pierantozzi, M ;
Semprini, R ;
Bernardi, G .
EUROPEAN JOURNAL OF NEUROLOGY, 1996, 3 (04) :354-362
[49]   Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist [J].
van de Witte, SV ;
Drukarch, B ;
Stoof, JC ;
Voorn, P .
MOLECULAR BRAIN RESEARCH, 1998, 61 (1-2) :219-223
[50]  
VERMA A, 1993, METHOD FIND EXP CLIN, V15, P515